You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

peginterferon alfa-2b

Showing 26 - 50 of 3,215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Mar 28, 2022

Childhood Craniopharyngioma Trial in United States (peginterferon alfa-2b, laboratory biomarker analysis)

Terminated
Has Results
  • Childhood Craniopharyngioma
  • peginterferon alfa-2b
  • laboratory biomarker analysis
  • Los Angeles, California
  • +8 more
Feb 20, 2020

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)

Not yet recruiting
  • Thymic Epithelial Tumor
  • rhGM-CSF，Peginterferon alfa-b2，radiation
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Metastatic Melanoma Trial in Copenhagen (Cyclophosphamide, Fludarabine, TIL infusion)

Completed
Has Results
  • Metastatic Melanoma
  • Copenhagen, Herlev, Denmark
    Center for Cancer Immune Therapy, Dept. of Haematology/Oncology
Jan 13, 2020

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

Not yet recruiting
  • Hypophosphatasia
  • Hartford, Connecticut
  • +29 more
Oct 6, 2023

Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

Recruiting
  • Adult T-cell Leukemia-Lymphoma
  • ATLL
  • Miami, Florida
    University of Miami
Jan 24, 2022

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

Antiviral Therapy for Patients With Liver Cancer After Surgery

Recruiting
  • Hepatocellular Carcinoma
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Jul 19, 2022

    Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)

    Recruiting
    • Cervical Dysplasia
    • HPV Infection
    • gel Interferon arm
    • gel Interferon and interferon suppository arm
    • Ulaanbaatar, Mongolia
      National Cancer Center
    Nov 14, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 1, 2022

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Suspended
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +18 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 4, 2022

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Multidisciplinary Support Program in Chronic Hepatitis C

    Completed
    Has Results
    • Hepatitis C, Chronic
    • Multidisciplinary support program
    • Barcelona, Spain
      Hospital del Mar
    Sep 15, 2021

    Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

    Recruiting
    • Primary Myelofibrosis, Prefibrotic Stage
    • Myelofibrosis
    • Ropeginterferon alfa-2b
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Jul 25, 2021

    Hepatitis C Trial in Durham (interferon alfa-2b, peginterferon alfa-2b, ribavirin, USP)

    Completed
    Has Results
    • Hepatitis C
    • interferon alfa-2b
    • +3 more
    • Durham, North Carolina
      Duke Clinical Research Institute
    Sep 24, 2019

    Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

    Completed
    Has Results
    • Kidney Cancer
    • recombinant interferon alfa
    • tretinoin liposome
    • New York, New York
    • +1 more
    Mar 17, 2022